Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
Majority of organizations are looking to increase investments in public and hybrid cloud
The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Ibara will drive AI-powered clinical research innovation
Subscribe To Our Newsletter & Stay Updated
